[
    {
        "category": "company",
        "datetime": 1743253500,
        "headline": "Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000",
        "id": 133622871,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Healthcare diagnostics equipment manufacturer, Idexx Laboratories (NASDAQ: IDXX), is the global leader in pet care.  Despite this incredible run, Idexx's current share price is the same as it was in late 2020, despite revenue growing by 50% and free cash flow (FCF) per share rising 87% over the same period.  This divergence between a company's improving financial results and its languishing share price is often a powerful combination for investors -- and I believe that could be the case with Idexx.",
        "url": "https://finnhub.io/api/news?id=8f6ce04efc9699cf33012fadb4b577657a4ca3358d3a68881a90f25effaa3bc9"
    },
    {
        "category": "company",
        "datetime": 1743180900,
        "headline": "IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors",
        "id": 133646351,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=fe83dddfa0963262266737d4d94a5090ad4fc45292f4a2d03ebb49f5601bb43d"
    },
    {
        "category": "company",
        "datetime": 1743119400,
        "headline": "ClearBridge Mid Cap Growth Portfolios Q4 2024 Commentary",
        "id": 133504297,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/185254884/image_185254884.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Mid-capitalization growth stocks surged during the fourth quarter. Top detractors within health care included ICON and IDEXX Laboratories. Read more here.",
        "url": "https://finnhub.io/api/news?id=ac5d9597b2a1bb35d19f36a5d57537c07d60b8fc037379f304357ed512ffef90"
    },
    {
        "category": "company",
        "datetime": 1743094500,
        "headline": "IDEXX Laboratories Inc. stock outperforms competitors on strong trading day",
        "id": 133496105,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock outperforms competitors on strong trading day",
        "url": "https://finnhub.io/api/news?id=8e7d88f28373db2959a0fe33e8639821351feac3c2b88091da6bc07b1356dfef"
    },
    {
        "category": "company",
        "datetime": 1743002033,
        "headline": "Is IDEXX Laboratories, Inc. (IDXX) The Best Pet Stock to Buy According to Billionaires?",
        "id": 133457383,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "We recently compiled a list of the 8 Best Pet Stocks to Buy According to Billionaires. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the other pet stocks. The pet industry is expected to continue growing in the coming years, driven by changing consumer preferences [\u2026]",
        "url": "https://finnhub.io/api/news?id=be1e2d9d1a0ef2c4303e0825ead30080a6ff9a36846109119fb93c1e5ac457c9"
    },
    {
        "category": "company",
        "datetime": 1742921760,
        "headline": "IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors",
        "id": 133483438,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=a68206131d045a74794e2b325ec028f442eb63eb832b0ecc7454036dd45b325c"
    },
    {
        "category": "company",
        "datetime": 1742834183,
        "headline": "Why IDEXX Laboratories, Inc. (IDXX) is Among the Best Diagnostics Stocks to Invest in Right Now",
        "id": 133349858,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the other best diagnostics stocks to invest in right now. Overview of the Clinical Diagnostics Market According to a report by [\u2026]",
        "url": "https://finnhub.io/api/news?id=0009685207b83fe129679645bea31e303a2c96e3a5e71f39305bb8267abc3ecf"
    },
    {
        "category": "company",
        "datetime": 1742824810,
        "headline": "IDEXX Laboratories Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution",
        "id": 133349860,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "In the last year, many IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) insiders sold a substantial stake in the company which...",
        "url": "https://finnhub.io/api/news?id=cc7ed00ebc648d4c4ba425a4457e0d8445277b5c7b9f0c86a0496b8b7d902ad9"
    },
    {
        "category": "company",
        "datetime": 1742452800,
        "headline": "Invesco Global Focus Fund Q4 2024 Commentary",
        "id": 133269217,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Class A shares at net asset value underperformed the MSCI All-Country World Growth Index but outperformed the Morningstar Global Growth Stock Funds Category average during Q4.",
        "url": "https://finnhub.io/api/news?id=55ffb63cfa856c1809c6a6e04bb0a1c7fc87468228a8b2c017088e66cc52cd0b"
    },
    {
        "category": "company",
        "datetime": 1742306220,
        "headline": "Should You Retain IDEXX Stock in Your Portfolio for Now?",
        "id": 133326539,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDXX stays on investors' radar due to the strength of its CAG Diagnostics business.",
        "url": "https://finnhub.io/api/news?id=339b64fedcc355175a9532b9485722fe4d887ddbbbb3fc5650ce28c06f129ee8"
    },
    {
        "category": "company",
        "datetime": 1742190029,
        "headline": "IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy'",
        "id": 133205753,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1288732000/image_1288732000.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth potential and a $1.5B repurchase plan.",
        "url": "https://finnhub.io/api/news?id=e4e85354947b5187db53f405e385413db660981100be6269ecdee949a4e6ea15"
    },
    {
        "category": "company",
        "datetime": 1741897863,
        "headline": "Tracking Ron Baron's BAMCO Portfolio - Q4 2024 Update",
        "id": 133165250,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1056792912/image_1056792912.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "BAMCO's latest 13F portfolio grew to $38.69B. Notable stake increases include CoStar Group, Vail Resorts, Hyatt Hotels, and Idexx Labs. See more here.",
        "url": "https://finnhub.io/api/news?id=e92aeb16300be7da14b7cf2c76b2ec3800c35765e628dbd315db11a00d6dee5a"
    },
    {
        "category": "company",
        "datetime": 1741884960,
        "headline": "IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors",
        "id": 133227575,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=b9a0d40a5703f9836c914edbc7378968e7a855fc2392c0ebf48310a0977fa9f8"
    },
    {
        "category": "company",
        "datetime": 1741883752,
        "headline": "Zoetis: Focusing On The High Margin Segments",
        "id": 133164243,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/500782479/image_500782479.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Zoetis divests its MFA segment to boost margins while focusing on profitable areas like genetics. Click here to find out why ZTS stock is a Buy.",
        "url": "https://finnhub.io/api/news?id=35dc1fed79052459e9b78cc2879075f36192e215b272ac9c991dfb99ee4f59a2"
    },
    {
        "category": "company",
        "datetime": 1741806525,
        "headline": "IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory",
        "id": 133189194,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Hidden Market Gems. In this article, we will summarize the bulls\u2019 thesis on IDXX. IDEXX Laboratories, Inc. (IDXX)\u2019s share was trading at $426.69 as of March 11th. IDXX\u2019s trailing and forward P/E were 39.98 and 36.36 respectively according to Yahoo Finance. IDEXX Laboratories, [\u2026]",
        "url": "https://finnhub.io/api/news?id=3e83520a20f3bdf79cfc66f41daf9b075642022e07a1dc84548210be7827593f"
    },
    {
        "category": "company",
        "datetime": 1741798500,
        "headline": "IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors",
        "id": 133227576,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=72b2e0de2d009942be9407a4f6ef08d5dc964d22c4c94289b819a9b825a3723e"
    },
    {
        "category": "company",
        "datetime": 1741786137,
        "headline": "Corporate Buyers Sign Deals with Texas Solar Energy Projects",
        "id": 133184646,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Technology company Cisco is among the groups involved in six virtual power purchase agreements (VPPAs) to secure energy from two solar power plants being developed in Texas.",
        "url": "https://finnhub.io/api/news?id=d0f6d4afffbcbb569bd5b176376a958a5c1eea48012915cdaae1ff40f8d34d80"
    },
    {
        "category": "company",
        "datetime": 1741760680,
        "headline": "IDEXX Laboratories: A Top Dog In The Pet Care Market",
        "id": 133147814,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/170882468/image_170882468.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "The pet care industry is growing, providing IDEXX with significant growth opportunities. Check out why I rate IDXX stock as a buy.",
        "url": "https://finnhub.io/api/news?id=6f403036c4bfc336779265a1b9123a5aa915f4fb29e9a9172195046f3a3f26aa"
    },
    {
        "category": "company",
        "datetime": 1741599300,
        "headline": "ClearBridge Mid Cap Growth Strategy Q4 2024 Commentary",
        "id": 133117560,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/816391550/image_816391550.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "The ClearBridge Mid Cap Growth Strategy performed in line with its Russell Midcap Growth Index benchmark during the fourth quarter. Click here to read the full commentary.",
        "url": "https://finnhub.io/api/news?id=eafd73a38e45cc3b01a42303868822c0b30ce0db065d5b30f7ab252d23114c33"
    },
    {
        "category": "company",
        "datetime": 1741269060,
        "headline": "Fidelity Growth Strategies Fund Q4 2024 Review",
        "id": 133067708,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367307631/image_1367307631.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "For the quarter, the fund's Retail Class shares gained 7.36%, underperforming the 8.14% advance of the benchmark Russell Midcap\u00c2\u00ae Growth Index. Read more here.",
        "url": "https://finnhub.io/api/news?id=cf3a19ecb80a4132fe3fc419500b88a963643bb15438de166dcb2eb25c5c020e"
    },
    {
        "category": "company",
        "datetime": 1741236600,
        "headline": "Baron Funds Q4 2024 Letter From Ron Baron",
        "id": 133050654,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/182846264/image_182846264.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Since their respective inceptions, 16 of 19 Baron mutual funds, representing 96.4% of Baron Funds\u00e2\u0080\u0099 AUM, have outperformed their primary benchmarks. Read more here.",
        "url": "https://finnhub.io/api/news?id=0ddd46730b3f9e92cec5553d92b1feaa026ba9b38ebcfbc3fe84b0e308ccf117"
    },
    {
        "category": "company",
        "datetime": 1741192211,
        "headline": "Idexx (IDXX) Down 5% Since Last Earnings Report: Can It Rebound?",
        "id": 133189196,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
        "url": "https://finnhub.io/api/news?id=7b94acc4bdf3a66fdfb67024f8395793a1da42ebc86c66bba0c90c0d8f961582"
    },
    {
        "category": "company",
        "datetime": 1741096980,
        "headline": "TimesSquare U.S. Focus Growth Strategy Q4 2024 Commentary",
        "id": 132979527,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1306669539/image_1306669539.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "In the U.S., the sweep by Trump\u00e2\u0080\u0099s Republican Party created expectations for a pro-business, lower regulatory environment with protectionist tariffs. Read more here.",
        "url": "https://finnhub.io/api/news?id=d6421165efac7be4d5239645a1d42c5e3640b121cc4338d304ad21b7e4313895"
    },
    {
        "category": "company",
        "datetime": 1741094760,
        "headline": "TimesSquare U.S. Mid Cap Growth Strategy Q4 2024 Commentary",
        "id": 132979338,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/639521796/image_639521796.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "In the U.S., the sweep by Trump\u00e2\u0080\u0099s Republican Party created expectations for a pro-business, lower regulatory environment with protectionist tariffs. Read more here.",
        "url": "https://finnhub.io/api/news?id=e588487de0246969500f182dd82184c02fd0520a289a1f2f5be9623d934ccf27"
    },
    {
        "category": "company",
        "datetime": 1741008604,
        "headline": "IDEXX Laboratories : Raymond James 46th Annual Institutional Investors Conference presentation",
        "id": 132955390,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "CREATING CLARITY Raymond James 46th Annual Institutional Investors Conference Jay Mazelsky ...",
        "url": "https://finnhub.io/api/news?id=eef663995cf75aad6ef9d7d752a9247f98a02ef640f4db1a949d799884596c25"
    },
    {
        "category": "company",
        "datetime": 1740602751,
        "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q4 2024 Update",
        "id": 132893007,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/538053368/image_538053368.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Read here for an update on Fundsmith's latest 13F portfolio shifts with reduced major stakes, new small positions, and notable disposals.",
        "url": "https://finnhub.io/api/news?id=4260df84acb1d040c8e5174d41bf079cdf4a02743d7da9afbddc6cd0b22b4c1b"
    },
    {
        "category": "company",
        "datetime": 1740395685,
        "headline": "IDEXX Laboratories Full Year 2024 Earnings: EPS Beats Expectations",
        "id": 133189197,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories ( NASDAQ:IDXX ) Full Year 2024 Results Key Financial Results Revenue: US$3.90b (up 6.5% from FY...",
        "url": "https://finnhub.io/api/news?id=7f8a67300adfbce420747aadf0dc2176aec8b6e759fbd789e931a6f3f523268f"
    },
    {
        "category": "company",
        "datetime": 1740115800,
        "headline": "Baron WealthBuilder Fund Q4 2024 Shareholder Letter",
        "id": 132826771,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/183865137/image_183865137.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Baron WealthBuilder Fund, a compilation of Baron Funds, increased in the fourth quarter of 2024, outperforming its benchmark, the S&P 500 Index.",
        "url": "https://finnhub.io/api/news?id=d1c2cb984f7a06c1cbd81c25487bae93c3f943a0cd9061d9d9da25abc9023d22"
    },
    {
        "category": "company",
        "datetime": 1740114600,
        "headline": "Baron Partners Fund Q4 2024 Shareholder Letter",
        "id": 132826711,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1149029523/image_1149029523.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Baron Partners Fund increased in the fourth quarter of 2024, outperforming its benchmark, the Russell Midcap Growth Index.",
        "url": "https://finnhub.io/api/news?id=51b0047434f7144b138d2b019c96702071c2809c7708590598611c81aac2ff47"
    },
    {
        "category": "company",
        "datetime": 1739981700,
        "headline": "Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks",
        "id": 133186682,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Every stock tells a story; it takes humans to find the meaning in it.",
        "url": "https://finnhub.io/api/news?id=2aca9f793c521e2e3baa66be924b7b6a9df9fd9f4dbd051328bcc138c851ca4b"
    },
    {
        "category": "company",
        "datetime": 1739883000,
        "headline": "Should You Hold IDEXX Stock in Your Portfolio for Now?",
        "id": 133189199,
        "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX's robust strength in the CAG Diagnostics business and strong global performance are highly promising.",
        "url": "https://finnhub.io/api/news?id=659b5365085336ee354520751596c4a04dc76185f50564d44340415565ad73d1"
    },
    {
        "category": "company",
        "datetime": 1739785500,
        "headline": "Parnassus Mid Cap Growth Fund Q4 And 2024 Annual Investment Commentary",
        "id": 132754062,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2192484336/image_2192484336.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "The Parnassus Mid Cap Growth Fund returned -2.45% (net) for Q4 2024, underperforming the Russell Midcap Growth Index. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=c9197e8b18cbfbbbd591417b58cfdb4ba97b39093d260597b9c86d1289f7cd16"
    },
    {
        "category": "company",
        "datetime": 1739539632,
        "headline": "IDEXX Laboratories (IDXX) Fell Due to Weakening of Clinical Visits by Patients",
        "id": 132711909,
        "image": "https://media.zenfs.com/en/insidermonkey.com/2cd8148157cf1b7ad501c38998155fc7",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Baron Funds, an investment management company, released its \u201cBaron Asset Fund\u201d fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. US equities ended the quarter higher primarily due to the market\u2019s strength following Donald Trump\u2019s election as president and the Republican majority in both houses of Congress. While Baron Asset [\u2026]",
        "url": "https://finnhub.io/api/news?id=4924b542fe3cf418664bd4607b11147244053beb2b7cfe92b4e18e3872a9fff0"
    },
    {
        "category": "company",
        "datetime": 1739473200,
        "headline": "IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences",
        "id": 132711910,
        "image": "https://s.yimg.com/ny/api/res/1.2/hvt.oPfe2RyT0pNRdlphLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0yMjA-/https://media.zenfs.com/en/business-wire.com/9147c7b7770af52eb82dc31f7ad905e8",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "WESTBROOK, Maine, February 13, 2025--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences:",
        "url": "https://finnhub.io/api/news?id=d6aa97873081479da1eea3224de414b1e2e5aadd8370b278630375ea147a55ea"
    },
    {
        "category": "company",
        "datetime": 1739365086,
        "headline": "Here\u2019s Why IDEXX Laboratories (IDXX) Declined in Q4",
        "id": 132711911,
        "image": "https://media.zenfs.com/en/insidermonkey.com/2cd8148157cf1b7ad501c38998155fc7",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S. equity indices ended the year with double-digit returns after generating modest returns in the fourth quarter of 2024. Conestoga\u2019s investment plans were hindered by the enthusiasm for everything [\u2026]",
        "url": "https://finnhub.io/api/news?id=cd445a930d27fdb5a11be2fed18faff8202ab04bb04ce5c34a3ff96556e5cd4d"
    },
    {
        "category": "company",
        "datetime": 1739198340,
        "headline": "Are Options Traders Betting on a Big Move in IDEXX (IDXX) Stock?",
        "id": 132711912,
        "image": "https://media.zenfs.com/en/zacks.com/a85eb7319e956e8beb6c9c5b0aadb1b7",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Investors need to pay close attention to IDEXX (IDXX) stock based on the movements in the options market lately.",
        "url": "https://finnhub.io/api/news?id=23af24fbca5b2b1cb5ad6c544d3fb447c59d41303a70d7ea20038a615ba3f3b3"
    },
    {
        "category": "company",
        "datetime": 1739186822,
        "headline": "IDEXX Laboratories And Its Real Value",
        "id": 132634564,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2047547013/image_2047547013.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion amidst recent challenges. Read the full stock report here.",
        "url": "https://finnhub.io/api/news?id=5bebfab76041b3385b7ab45c3f3dd615412c4a25cf8c84f96821cdc5e43c5146"
    },
    {
        "category": "company",
        "datetime": 1738930154,
        "headline": "Why Idexx Labs Stock Rocketed Higher This Week",
        "id": 132711913,
        "image": "https://g.foolcdn.com/editorial/images/806833/gettyimages-1725491683-1.jpg",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Shares of leading pet healthcare diagnostics provider Idexx Laboratories (NASDAQ: IDXX) were up by 9% this week as of 4 p.m. ET Thursday, according to data provided by S&P Global Market Intelligence.  Idexx Labs reported fourth-quarter earnings Monday morning that surpassed analysts' expectations for revenue and earnings per share (EPS).  After pulling forward growth during the pandemic, the veterinary industry has yet to return to normal, making Idexx's Q4 results and guidance reassuring for investors.",
        "url": "https://finnhub.io/api/news?id=8bbd3fcc3d7f5ff794a5f0060c9f13ba2578dd137a6ab7a0d1097f3352e6fe54"
    },
    {
        "category": "company",
        "datetime": 1738852263,
        "headline": "IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future",
        "id": 132580369,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1288732000/image_1288732000.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.",
        "url": "https://finnhub.io/api/news?id=8d74ad99bff25cb7ef1a635cfcf359137b7813ae8727cb3c5e4da0c0d8206981"
    },
    {
        "category": "company",
        "datetime": 1738850340,
        "headline": "Baron Growth Fund Q4 2024 Shareholder Letter",
        "id": 132580275,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/483722533/image_483722533.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Baron Growth Fund\u00c2\u00ae (the Fund) gained 5.02% (Institutional Shares) for the year ended December 31, 2024. Read more here.",
        "url": "https://finnhub.io/api/news?id=67623aecdece1380b9fe60044734d2a202eafc5dd1b9f35a5f88ba866929ccce"
    },
    {
        "category": "company",
        "datetime": 1738729602,
        "headline": "IDEXX Laboratories, Inc. : Idexx Laboratories looks set for an upward trend",
        "id": 132559930,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "Founded in 1983, Idexx Laboratories has established itself as a world leader in the design, development and marketing of diagnostic test instruments, mainly for the veterinary sector, but also for...",
        "url": "https://finnhub.io/api/news?id=dd7189efc076fd25eb86781b65eafd590e43ab7d773e1faec32d64d2c950e788"
    },
    {
        "category": "company",
        "datetime": 1738705254,
        "headline": "IDEXX Laboratories (IDXX) Reports an \u201cAmazing Quarter\u201d \u2013 Jim Cramer Calls It a \u201cSafety Stock\u201d",
        "id": 132711914,
        "image": "https://media.zenfs.com/en/insidermonkey.com/dc5a2bcb6b4c16a43cb5b4ba98feb139",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "We recently published a list of Jim Cramer On 9 Stocks That Are Rallying Despite Tariff Worries. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against other stocks that Jim Cramer discusses as rallying despite tariff worries. On Monday, Jim Cramer, the host of Mad Money, [\u2026]",
        "url": "https://finnhub.io/api/news?id=70b6f693573abf69b9e27a8437afa6afedbef08757cbcd0bacaf8b6774f732c0"
    },
    {
        "category": "company",
        "datetime": 1738652547,
        "headline": "IDEXX Laboratories Inc (IDXX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...",
        "id": 132711915,
        "image": "https://media.zenfs.com/en/us.finance.gurufocus/c416c0f93ca9a69b120fac73cb561945",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories Inc (IDXX) reports robust Q4 results with significant gains in diagnostic revenues and strategic advancements in technology.",
        "url": "https://finnhub.io/api/news?id=e9f4eb509a8ca8d67ccdb844062e48c956871867f9e84aa2582924fc048e85c9"
    },
    {
        "category": "company",
        "datetime": 1738646431,
        "headline": "Q4 2024 IDEXX Laboratories Inc Earnings Call",
        "id": 132711916,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Q4 2024 IDEXX Laboratories Inc Earnings Call",
        "url": "https://finnhub.io/api/news?id=b25bb0c7fc77ddcf29843262b1389ef08e15971fe9a62c639ff91f9e73a98108"
    },
    {
        "category": "company",
        "datetime": 1738618950,
        "headline": "S&P 500 Gains and Losses Today: Index Falls Following Tariff Announcements",
        "id": 132574532,
        "image": "https://www.investopedia.com/thmb/W5gf3IhDEUUcIbBOXvmw9FoN_Nc=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/INV_ModernaSign_GettyImages-1288670274-2f734a7a31a74107b40c480d9b2906cc.jpg",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "The S&P 500 fell 0.8% on Monday, Feb. 3, as investors reacted to tariffs on major U.S. trading partners while awaiting key earnings and labor market data.",
        "url": "https://finnhub.io/api/news?id=81e90e37656c8ff4307bc156208c4aa536c0d9e8f0db5fd0450f18fdf71ee7ff"
    },
    {
        "category": "company",
        "datetime": 1738616573,
        "headline": "Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High",
        "id": 132711918,
        "image": "https://media.zenfs.com/en/ibd.com/6c26281518f16dee4dab56aa728c2562",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Idexx Laboratories handily beat Wall Street's fourth-quarter expectations Monday, and Idexx stock gapped up to a four-month high.",
        "url": "https://finnhub.io/api/news?id=80d75babb0429ecb5a0e5994bc17ea19694a054c5e1870ca41fc6dc6c3bb658d"
    },
    {
        "category": "company",
        "datetime": 1738601503,
        "headline": "Top Stock Movers Now: Constellation Brands, IDEXX, Tyson Foods, and More",
        "id": 132711919,
        "image": "https://www.investopedia.com/thmb/2-JLEuXcLkXZn9F5bX8v5eYpX2s=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1910383099-322767129c6e4a8c9713dd01aa1a2571.jpg",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "U.S. equities slumped at midday, but were off their lows after President Trump paused new tariffs on Mexico.",
        "url": "https://finnhub.io/api/news?id=da904cec2956a6189d23431631b9f43b666ddc24ccdaa8576a6fcc39f6e49fa6"
    },
    {
        "category": "company",
        "datetime": 1738600950,
        "headline": "Idexx Soars 10.5% After Crushing Q4 Estimates -- Big Buybacks and New Cancer Test Drive 2025 Outlook",
        "id": 132711920,
        "image": "https://media.zenfs.com/en/us.finance.gurufocus/20d06a4752d4cedda6496ba4b79dba76",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Strong earnings, a $1.5B buyback, and game-changing diagnostics send Idexx stock soaring--investors take notice.",
        "url": "https://finnhub.io/api/news?id=fbe771c5f7587e45ec6454e89a3fea80a1638e6fe258d5f718a414dcead6b921"
    },
    {
        "category": "company",
        "datetime": 1738600260,
        "headline": "Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today\u2019s Top S&P 500 Performers.",
        "id": 132711921,
        "image": "https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Idexx Laboratories  stock was rising sharply Monday, even as the  and major indexes remained in the red.  The  rebounded some 500 points after President Donald Trump halted his plans for 25% tariffs on imports from Mexico for a month.  Shares of  Idexx Laboratories  were up 12% on Monday and on track for the largest same-day percentage increase since Nov. 10, 2022, according to Dow Jones Market Data.",
        "url": "https://finnhub.io/api/news?id=eba424bdf3bc932ffda20c4023f1c7179009657db72e4ba4fc1fac85426f6465"
    },
    {
        "category": "company",
        "datetime": 1738598700,
        "headline": "IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices",
        "id": 132711922,
        "image": "https://www.investopedia.com/thmb/8xRqTHu7OL276uxAuJWOqIUHmr4=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2189110478-19c6e54a7f2643f3bf42fb23f5b4735b.jpg",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price increases.",
        "url": "https://finnhub.io/api/news?id=ad3a8f4988fdbbb1227676efecbe8d25f0eb1e23f57cbeb73ffdee89eaa99069"
    },
    {
        "category": "company",
        "datetime": 1738598094,
        "headline": "Why IDXX Is Soaring Today",
        "id": 132711923,
        "image": "https://s.yimg.com/ny/api/res/1.2/ikONL9zPOKV5naBl.isbpw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/b5ee69f6db67b9c44e92597291bdbf62",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Pet healthcare firm Idexx (IDXX) is jumping 10% after delivering better-than-expected fourth-quarter financial results. The midpoint of the company\u2019s 2025 earnings per share guidance range also came in above analysts\u2019 average outlook. Idexx\u2019s Q4 Results and Its 2025 Guidance The company\u2019s Q4 sales rose 5.8% versus the same period a year earlier to $954 million. [\u2026]",
        "url": "https://finnhub.io/api/news?id=a00fd5e2c5471fb69a60f8d221e860c8b93541020728cc0a123ded86ca2828f6"
    },
    {
        "category": "company",
        "datetime": 1738594287,
        "headline": "Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?",
        "id": 132711924,
        "image": "https://media.zenfs.com/en/Benzinga/bf1e7b0008f7dbf284e0486fa7c27c6f",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 million, beating the consensus of $934.99 million, up 6% on a reported and organic basis in the fourth quarter, driven by Companion Animal Group (CAG) growth of 6% as reported and organically to $870.47 million. CAG Diagnostics recurring revenue gains of 6% reported and 7% organic in the quarter were support",
        "url": "https://finnhub.io/api/news?id=06c5d8e9c32b3336c23a618bc09c5414cb0e7a02e1b047013d5fba53302bc306"
    },
    {
        "category": "company",
        "datetime": 1738593420,
        "headline": "Wall Street Lunch: That Was Fast - U.S. Tariffs On Mexico Delayed",
        "id": 132538812,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1089424824/image_1089424824.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "The delay in U.S. tariffs on Mexico led to a reversal in stock market losses and the U.S. dollar's gains against the peso and loonie.",
        "url": "https://finnhub.io/api/news?id=f31e083f646e72b84c7184483da918398099b50d2cd1411dd03399b14b6c4ffe"
    },
    {
        "category": "company",
        "datetime": 1738593005,
        "headline": "Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say",
        "id": 132711925,
        "image": "https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
        "url": "https://finnhub.io/api/news?id=e886cc9969c728b5252a5a4cbbeb27793a397087b75f39fd7f4fa47c7671c7b5"
    },
    {
        "category": "company",
        "datetime": 1738590780,
        "headline": "IDEXX Q4 Earnings and Revenues Top Estimates, Stock Up in Pre-Market",
        "id": 132711926,
        "image": "https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDXX delivers better-than-expected earnings and revenues in the fourth quarter of 2024.",
        "url": "https://finnhub.io/api/news?id=f7f666b0c4452ffc320700123aa935b60c88224d2fc09270378cec078d0e904f"
    },
    {
        "category": "company",
        "datetime": 1738586402,
        "headline": "Idexx Laboratories (IDXX) Q4 Earnings and Revenues Beat Estimates",
        "id": 132711927,
        "image": "https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Idexx (IDXX) delivered earnings and revenue surprises of 9.17% and 1.87%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
        "url": "https://finnhub.io/api/news?id=d9032d9cff4935b58423bfde92749829dcb1379f12cec1a73b52d6d77e0494a4"
    },
    {
        "category": "company",
        "datetime": 1738583210,
        "headline": "Idexx: Q4 Earnings Snapshot",
        "id": 132711928,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "The Westbrook, Maine-based company said it had profit of $2.62 per share. The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.40 per share.",
        "url": "https://finnhub.io/api/news?id=f1f44c758860e0e3883a73b241ca7c52f9b6a504aff5d1385f2b8b513e4b0d62"
    },
    {
        "category": "company",
        "datetime": 1738581974,
        "headline": "IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript",
        "id": 132528902,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ETCompany ParticipantsBrian McKeon - Chief Financial...",
        "url": "https://finnhub.io/api/news?id=01d2602cc62aed9f4847dd34dfd989c8b6b8e23895caa88cb6d0188617e3d1fd"
    },
    {
        "category": "company",
        "datetime": 1738569413,
        "headline": "Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits",
        "id": 132520093,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to...",
        "url": "https://finnhub.io/api/news?id=cefc45b5c82c15a42b026269ec663d2aee0496bda6341e692764eb10c2aedc9a"
    },
    {
        "category": "company",
        "datetime": 1738567800,
        "headline": "S&P 500 Futures Drop in Premarket Trading; Watsco B, Oklo Lag",
        "id": 132531217,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "S&P 500 Futures Drop in Premarket Trading; Watsco B, Oklo Lag",
        "url": "https://finnhub.io/api/news?id=2f941a5f7a710c8a2954e07acf6974c14de810d63542a2bb5810e3d01fa1e7e6"
    },
    {
        "category": "company",
        "datetime": 1738565051,
        "headline": "IDEXX Laboratories : Q4 2024 Earnings Snapshot",
        "id": 132519679,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "IDEXX Q4 & Full Year 2024 Earnings Highlights Revenue ...",
        "url": "https://finnhub.io/api/news?id=e61ee823216260ff4f5c9f7d5c2b5d81eac3db969b76866433512361c50fdd5d"
    },
    {
        "category": "company",
        "datetime": 1738564323,
        "headline": "IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results",
        "id": 132519601,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "Achieves fourth quarter revenue growth of 6% as reported and on an organic basis, driven by CAG Diagnostics recurring revenue growth of 6% reported and 7% organicSolid growth supported by...",
        "url": "https://finnhub.io/api/news?id=bb53ce11e35177dccd4d2b3ba7d1df006f8c3658c92f6165a97b7104fee562e7"
    },
    {
        "category": "company",
        "datetime": 1738476596,
        "headline": "Wall Street Week Ahead",
        "id": 132514375,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/175464726/image_175464726.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Stay informed with the latest financial updates! Get a daily podcast of Wall Street Breakfast on Seeking Alpha, iTunes, and Spotify by 8:00 a.m.",
        "url": "https://finnhub.io/api/news?id=b628db79bec8b4ba19db49d42ef374af40f7c9effdf8a9adc7a8aa86c521dc6d"
    },
    {
        "category": "company",
        "datetime": 1738407600,
        "headline": "Busy Earnings Season Continues With Alphabet, Disney, Palantir To Report Results",
        "id": 132510711,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Tech biggies continue to report earnings this week. A bunch of labor reports are to be released. EU inflation data will be released on Wednesday. See more here.",
        "url": "https://finnhub.io/api/news?id=4183cd54aed2c97e8c317416c61a1ac1dab36e61d22ba5d773abed5f29b17495"
    },
    {
        "category": "company",
        "datetime": 1738129500,
        "headline": "Baron Asset Fund Q4 2024 Shareholder Letter",
        "id": 132491508,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1371036089/image_1371036089.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Baron Asset Fund declined in the fourth quarter of 2024, underperforming its benchmark, the Russell Midcap Growth Index. Click here to read the full commentary. ",
        "url": "https://finnhub.io/api/news?id=db5bbcec25695a611b7b68b502502ad89c172849d227876dd2bff9572325f6ce"
    },
    {
        "category": "company",
        "datetime": 1737996900,
        "headline": "IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors",
        "id": 132531220,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=8ca840325efe143b49514468d5f7f212ffc8455452b14f1817f2e76a553110fe"
    },
    {
        "category": "company",
        "datetime": 1737882780,
        "headline": "Conestoga Capital Advisors Q4 2024 Quarterly Commentary",
        "id": 132473786,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1688767071/image_1688767071.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "U.S. equity indices generated modest returns in the fourth quarter of 2024, and closed out the full year with double digit returns for the second year in a row.",
        "url": "https://finnhub.io/api/news?id=e1a28e98a947da469f95e2773d5b14ad45324702d9e9b0c031addc7b6bc3df90"
    },
    {
        "category": "company",
        "datetime": 1737535500,
        "headline": "Baron Focused Growth Fund Q4 2024 Shareholder Letter",
        "id": 132442321,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/165180102/image_165180102.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Baron Focused Growth Fund advanced during the fourth quarter of 2024, outperforming its benchmark, the Russell 2500 Growth Index. Read more here.",
        "url": "https://finnhub.io/api/news?id=ba17ccf0e8abc80d156735b48199b05d69c042024730069b1605eea9a4f31829"
    },
    {
        "category": "company",
        "datetime": 1737044163,
        "headline": "IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results",
        "id": 132410388,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "IDEXX Laboratories, Inc. , a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025, before the...",
        "url": "https://finnhub.io/api/news?id=2c45fd0e5b253406cd898c6d98cb336cf7d3db5294194f63f3d6b1d6a356a2b1"
    },
    {
        "category": "company",
        "datetime": 1736745180,
        "headline": "Fundsmith Equity Fund 2024 Annual Letter To Shareholders",
        "id": 132386132,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/483722533/image_483722533.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Our Fund is the second-best performer since its inception in November 2010 in the Investment Association Global sector of 162 funds. Read more here.",
        "url": "https://finnhub.io/api/news?id=47795a6b722817673b57b68f32b5a0ac46e93c537e01b91b82542fc7ea50ff64"
    },
    {
        "category": "company",
        "datetime": 1735224311,
        "headline": "Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term",
        "id": 132164965,
        "image": "https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
        "url": "https://finnhub.io/api/news?id=943b1698e7658384e726ab7680a8d7738043806c0288ce0e5847548601756bec"
    },
    {
        "category": "company",
        "datetime": 1735059660,
        "headline": "IDEXX Laboratories Inc. stock rises Tuesday, still underperforms market",
        "id": 132155386,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock rises Tuesday, still underperforms market",
        "url": "https://finnhub.io/api/news?id=8877c26f4b1c8e5cd9e643e7cfcde13b0664138328128da4e8230fecb77ddcc5"
    },
    {
        "category": "company",
        "datetime": 1734973260,
        "headline": "IDEXX Laboratories Inc. stock rises Monday, still underperforms market",
        "id": 132155387,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock rises Monday, still underperforms market",
        "url": "https://finnhub.io/api/news?id=9aad046bca46ab747db547eb3264b64fd05a10e4f248ef164e00ad79bed16f65"
    },
    {
        "category": "company",
        "datetime": 1734962422,
        "headline": "IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly",
        "id": 132123222,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...",
        "url": "https://finnhub.io/api/news?id=ef73eadbc3fef4c2b3414bebb8f0b5c0830ab1bbee85496e94347ac7056b74c0"
    },
    {
        "category": "company",
        "datetime": 1734735985,
        "headline": "Tracking Ron Baron's BAMCO Portfolio - Q3 2024 Update",
        "id": 132085085,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1056792912/image_1056792912.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Read more on BAMCO's Q3 2024 portfolio growth and focus on key securities like Tesla, Gartner, and more for long-term investment opportunities.",
        "url": "https://finnhub.io/api/news?id=c29b4743a54114857d77b0218213710c42289d89a83a9871fd6c10e8626772d2"
    },
    {
        "category": "company",
        "datetime": 1734728551,
        "headline": "Jim Cramer on IDEXX Laboratories (IDXX): Is This Pet Stock Poised for a Comeback?",
        "id": 132085455,
        "image": "https://s.yimg.com/ny/api/res/1.2/49Eav.P8JXuAIU2r8SjZcQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "We recently compiled a list of the 7 Stocks that Jim Cramer Recently Discussed. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the other stocks that Jim Cramer has recently discussed. Jim Cramer, host of Mad Money, recently addressed how investors can sometimes lose sight [\u2026]",
        "url": "https://finnhub.io/api/news?id=34ca29491f061aa6cc5910087d0525ec64b2b19493725d238c1015ca05c61318"
    },
    {
        "category": "company",
        "datetime": 1734714060,
        "headline": "IDEXX Laboratories Inc. stock rises Friday, still underperforms market",
        "id": 132155388,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock rises Friday, still underperforms market",
        "url": "https://finnhub.io/api/news?id=cc1a9377cec04f48ce4b18ecc25d62d2c480b95ba52b74677d331b110ffdfab2"
    },
    {
        "category": "company",
        "datetime": 1734627660,
        "headline": "IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day",
        "id": 132155389,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day",
        "url": "https://finnhub.io/api/news?id=cabb040595face06a1638caee3fc3b00577a956be892d0dee3ffbc68343af79c"
    },
    {
        "category": "company",
        "datetime": 1734620940,
        "headline": "SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX",
        "id": 132052508,
        "image": "https://media.zenfs.com/en/globenewswire.com/f43c17ef33dd07f66cf4363cd16a4a3f",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Synopsys, Inc. Named Outstanding Leader, Nell Triplett of Juniper Networks Awarded Outstanding Executive, and IDEXX Laboratories, Inc. Recognized as Breakthrough Corporate LeaderBOSTON, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Sustainability Roundtable, Inc. (SR Inc), a leader in strategic advisory and support services, proudly announces the recipients of its 2024 Sustainable Business & Enterprise Roundtable (SBER) Awards. Presented the eve before its Summit for Sustainable Business VIII: Decarbonizing",
        "url": "https://finnhub.io/api/news?id=fb0c897744a6315f7c58a525925d7405ffd00e3c493a9caba7eb13960e6fdb7b"
    },
    {
        "category": "company",
        "datetime": 1734606014,
        "headline": "IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 9.3% CAGR delivered to shareholders",
        "id": 132058664,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "While IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) shareholders are probably generally happy, the stock hasn't had...",
        "url": "https://finnhub.io/api/news?id=84a3856bb08373393dd57840a1fbbdb14db7ad7d1b0cee97c06d06e9219463df"
    },
    {
        "category": "company",
        "datetime": 1734097500,
        "headline": "A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025",
        "id": 131965982,
        "image": "https://g.foolcdn.com/editorial/images/799957/gettyimages-1725491683.jpg",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Two companies that fit this description now are animal healthcare specialists Idexx Laboratories (NASDAQ: IDXX) and Zoetis (NYSE: ZTS).  While Idexx is already one of my daughter's core holdings and Zoetis is one of mine, I firmly agree that adding to your long-term winners over time is an outperforming proposition -- a notion espoused by Motley Fool co-founder David Gardner.  Idexx and Zoetis are currently down 37% and 28%, respectively, from their all-time highs -- yet they're still beating the S&P 500 on a total-return basis over the past decade.",
        "url": "https://finnhub.io/api/news?id=64f0afc52fee8d75367513f5421cd4581d3fa3a49ac029cc22e226d00cb9edb4"
    },
    {
        "category": "company",
        "datetime": 1734087616,
        "headline": "What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate?",
        "id": 131964920,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) saw significant share price movement during recent months on the NASDAQGS...",
        "url": "https://finnhub.io/api/news?id=838911a9dd471712821f850a8c3991b6abeefa3197655f5f0bb5ba1f58352cc0"
    },
    {
        "category": "company",
        "datetime": 1733932680,
        "headline": "Global Expansion to Support IDEXX Stock Despite Macroeconomic Issues",
        "id": 131923362,
        "image": "https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX focuses on growing its global commercial capability to sustain strong CAG Diagnostics recurring revenue growth.",
        "url": "https://finnhub.io/api/news?id=7e81d9366a1c8440adae15def19709ace03a5ffc4b375ccbe6d899c427b566ce"
    },
    {
        "category": "company",
        "datetime": 1733928611,
        "headline": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio",
        "id": 131923363,
        "image": "https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
        "url": "https://finnhub.io/api/news?id=c15a81e1c0b9aeea2cee1c770d7f29acfe16d0635e2f77018be4e30019e4f313"
    },
    {
        "category": "company",
        "datetime": 1733841911,
        "headline": "Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick",
        "id": 131903337,
        "image": "https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
        "url": "https://finnhub.io/api/news?id=e186f89af3e9745f283be825443e07ee37794ec76809375d15f17615511d8a87"
    },
    {
        "category": "company",
        "datetime": 1733747400,
        "headline": "IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization",
        "id": 131871887,
        "image": "https://s.yimg.com/ny/api/res/1.2/xyizcUuiNObHLd74nBi.MQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0yMjA-/https://media.zenfs.com/en/business-wire.com/d38a37e8436211eaf773bd04ce6d9684",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "WESTBROOK, Maine, December 09, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that the Company\u2019s Board of Directors authorized an increase in its ongoing share repurchase program, authorizing the repurchase of up to five million additional shares of the Company\u2019s common stock. Repurchases may be made at management\u2019s discretion from time to time in the open market (including through Rule 10b5-1 plans) or in negotiated transactions. The",
        "url": "https://finnhub.io/api/news?id=bce2941dcee2518a6f1bd8cb6544919a776bf4d2d024c7a3802fcdf86c8af0a3"
    },
    {
        "category": "company",
        "datetime": 1733745634,
        "headline": "IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?",
        "id": 131871888,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "With its stock down 12% over the past three months, it is easy to disregard IDEXX Laboratories (NASDAQ:IDXX). But if...",
        "url": "https://finnhub.io/api/news?id=b524b0d6e66332d314dc5b6bfb330dd362c397014b8b4acb84c4503510f2a6bd"
    },
    {
        "category": "company",
        "datetime": 1733729765,
        "headline": "IDEXX Laboratories : Announces Increase in Share Repurchase Program Authorization Form 8 K",
        "id": 131868073,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization WESTBROOK, Maine, December 9, 2024-IDEXX Laboratories, Inc. , a global leader in pet...",
        "url": "https://finnhub.io/api/news?id=e1518c0cb22d22edaebe909876a3e778de633f5fce59ac3302bb609d9369bb21"
    },
    {
        "category": "company",
        "datetime": 1733331540,
        "headline": "IDEXX Laboratories Inc. stock rises Wednesday, still underperforms market",
        "id": 131785911,
        "image": "",
        "related": "IDXX",
        "source": "MarketWatch",
        "summary": "IDEXX Laboratories Inc. stock rises Wednesday, still underperforms market",
        "url": "https://finnhub.io/api/news?id=efde1b5e4d90d8c7c332b1fef1309f500dd1474d92d7cc58ea6d7b6837beeffa"
    },
    {
        "category": "company",
        "datetime": 1733255572,
        "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q3 2024 Update",
        "id": 131760438,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/538053368/image_538053368.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Fundsmith\u00e2\u0080\u0099s 13F portfolio value increased from $24.54B to $25.28B in Q3 2024. Check out the major stake increases and notable holdings.",
        "url": "https://finnhub.io/api/news?id=28c23d49449f9f065fcb31e08b3732e06fae3cf5fbabed416d1178701fc4066b"
    },
    {
        "category": "company",
        "datetime": 1732971612,
        "headline": "Estimating The Fair Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)",
        "id": 131723451,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Key Insights Using the 2 Stage Free Cash Flow to Equity, IDEXX Laboratories fair value estimate is US$407 Current share...",
        "url": "https://finnhub.io/api/news?id=7ea2e4d95c04818eb0de32aff025913c79fca8e1144b1300a01c5ca526f9d465"
    },
    {
        "category": "company",
        "datetime": 1732871029,
        "headline": "Zoetis: Healing Paws, Growing Profits",
        "id": 131706458,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1308557660/image_1308557660.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Zoetis is active in multiple segments that are all expected to grow at a CAGR of 4% or more.",
        "url": "https://finnhub.io/api/news?id=096ae76af9a1535cd8df764da6e2b7dc6d42b95bbfbf390bcb554c819d361fd4"
    },
    {
        "category": "company",
        "datetime": 1732716054,
        "headline": "Why Is IDEXX Laboratories, Inc. (IDXX) Among the Worst Performing Healthcare Stocks in 2024?",
        "id": 131669412,
        "image": "https://s.yimg.com/ny/api/res/1.2/49Eav.P8JXuAIU2r8SjZcQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the other healthcare stocks. The Evolving Landscape of Global Healthcare Spending and Innovation The healthcare industry remains a vital and resilient sector which is [\u2026]",
        "url": "https://finnhub.io/api/news?id=81c4bc414be2cfdb78068c5800c80524c76c69f3f31d7efd3880ebc8b7208062"
    },
    {
        "category": "company",
        "datetime": 1732657020,
        "headline": "Invesco American Franchise Fund Q3 2024 Commentary",
        "id": 131655629,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/682049968/image_682049968.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Invesco American Franchise Fund currently favors a balance of high quality companies with resilient growth and early cyclical companies with potential to benefit from lower interest rates.",
        "url": "https://finnhub.io/api/news?id=a0a53752da817cd91eeb9a3adcc1d8ca9f7f56ea34d728cc416e1dafc74310d6"
    },
    {
        "category": "company",
        "datetime": 1732248965,
        "headline": "IDEXX Announces CFO Transition - IDEXX US",
        "id": 131558827,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "* Brian McKeon to Retire from IDEXX in June 2025* Andrew Emerson, Senior Vice President, Corporate and CAG Finance, to Serve as IDEXX's Next CFOWESTBROOK, Maine - IDEXX Laboratories, Inc. , a global...",
        "url": "https://finnhub.io/api/news?id=005406ebeb565dad61337316a9be5c9b27d8741642a3fce2507080eb049d9600"
    },
    {
        "category": "company",
        "datetime": 1732192200,
        "headline": "IDEXX Announces CFO Transition",
        "id": 131537071,
        "image": "",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "WESTBROOK, Maine, November 21, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon has decided to retire from IDEXX effective June 1, 2025. Andrew Emerson, currently Senior Vice President, Corporate and Companion Animal Group (\"CAG\") Finance, will succeed Mr. McKeon as IDEXX\u2019s Executive Vice President, Chief Financial Officer and Treasurer, effective March 1, 2025. Mr. McKeon will serve as EVP and Special Advisor to the C",
        "url": "https://finnhub.io/api/news?id=eefd10c5455ec302972add82f978bd880e52bcb742c1ff712b32a7c932a7d7ee"
    },
    {
        "category": "company",
        "datetime": 1732174564,
        "headline": "IDEXX Laboratories : Announces CFO Transition Form 8 K",
        "id": 131536563,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "IDEXX Announces CFO Transition Brian McKeon to Retire from IDEXX in June 2025 Andrew Emerson, Senior Vice President, Corporate and CAG Finance, to Serve as IDEXX's Next...",
        "url": "https://finnhub.io/api/news?id=59bddb6108e5be6e4f0291b9912928a7cf4d892eb66c4fcb48a29ab7272e7560"
    },
    {
        "category": "company",
        "datetime": 1732024808,
        "headline": "IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet",
        "id": 131487627,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...",
        "url": "https://finnhub.io/api/news?id=f0b9c45cc32bcd46c971a80ea38c93cf4edb9b41d8372bb891ec61af267e81fb"
    },
    {
        "category": "company",
        "datetime": 1732009560,
        "headline": "BlackRock Mid-Cap Growth Equity Fund Q3 2024 Commentary",
        "id": 131471386,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "BlackRock Mid-Cap Growth Equity Fund posted returns of 5.79% (Institutional shares) and 5.73% (Investor A shares, without sales charge) for the third quarter of 2024.",
        "url": "https://finnhub.io/api/news?id=201b863e6ac9b617299da3af35c8f0932980d201c40640afd7ff3c7c724cb40b"
    },
    {
        "category": "company",
        "datetime": 1731903372,
        "headline": "Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy",
        "id": 131438224,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/601800909/image_601800909.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS stock a Buy now.",
        "url": "https://finnhub.io/api/news?id=b02e8a4d54768a2158d8e4696333123f7e491d50d8bf941ea6c0fab1b2b86d91"
    },
    {
        "category": "company",
        "datetime": 1731675629,
        "headline": "IDEXX Laboratories (NASDAQ:IDXX) shareholders have earned a 10% CAGR over the last five years",
        "id": 131375434,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) shareholders might be concerned after seeing the share price drop 14% in the...",
        "url": "https://finnhub.io/api/news?id=3eb8c962f6a81f29ba1d42f1ad1cbdadd0958b23db76cd25be3527d4937bd2cc"
    },
    {
        "category": "company",
        "datetime": 1731268202,
        "headline": "IDEXX Laboratories Q3: Weak End-Market Demand Continues",
        "id": 131277860,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1885088156/image_1885088156.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "IDEXX's Q3 results showed a 2.1% decline in same-store clinical visits and missed market expectations. Read why I reiterate a Sell rating on IDXX stock.",
        "url": "https://finnhub.io/api/news?id=22eeef407588ac142f192eefe275dba6ec91292672ac04ea5dd3ed82be79d93f"
    },
    {
        "category": "company",
        "datetime": 1731240024,
        "headline": "Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?",
        "id": 131273191,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Let's talk about the popular IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's shares saw significant share price...",
        "url": "https://finnhub.io/api/news?id=7994d44eca2a31af3aa65290ae5beaca71a7d7b3cabec8d23170ac302fc5886a"
    },
    {
        "category": "company",
        "datetime": 1730987068,
        "headline": "Is IDEXX Laboratories (IDXX) The Best Pet Stock To Invest In According To Analysts?",
        "id": 131160411,
        "image": "https://s.yimg.com/ny/api/res/1.2/iyqOMJnj0.pbBD_kNm5H3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xMjAy/https://media.zenfs.com/en/insidermonkey.com/960810956cc596a1d2a75c48dc6dcecf",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "We recently compiled a list of the 10 Best Pet Stocks To Invest In According to Analysts. In this article, we are going to take a look at where IDEXX Laboratories Inc. (NASDAQ:IDXX) stands against the other pet stocks. Pet Industry at a Glance The pet industry is a rapidly growing sector. It was valued [\u2026]",
        "url": "https://finnhub.io/api/news?id=f848d53bf851bfcb69a95e5e9d1ee783a78758ea54e1dec4df0f9310a93c9e57"
    },
    {
        "category": "company",
        "datetime": 1730966400,
        "headline": "Aristotle Focus Growth Q3 2024 Commentary",
        "id": 131153459,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305170107/image_1305170107.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "For Q3 2024, Aristotle Atlantic\u00e2\u0080\u0099s Focus Growth Composite posted a total return of 2.84% gross of fees, underperforming the 3.19% total return of the Russell 1000 Growth Index.",
        "url": "https://finnhub.io/api/news?id=93091aca45c311f2693c963741d8183c95f2a5dd709f8ac4c48e9afcaa893eda"
    },
    {
        "category": "company",
        "datetime": 1730963700,
        "headline": "Aristotle Large Cap Growth Q3 2024 Commentary",
        "id": 131152190,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1503371245/image_1503371245.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "For Q3 2024, Aristotle Atlantic\u00e2\u0080\u0099s Large Cap Growth Composite posted a total return of 1.26% gross of fees, underperforming the 3.19% return of the Russell 1000 Growth Index.",
        "url": "https://finnhub.io/api/news?id=66a7758ae364fb7c30121e8972bba8535dfc7147b42019167e4a920e38680e12"
    },
    {
        "category": "company",
        "datetime": 1730901619,
        "headline": "Could The Market Be Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Its Attractive Financial Prospects?",
        "id": 131108751,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "With its stock down 13% over the past month, it is easy to disregard IDEXX Laboratories (NASDAQ:IDXX). But if you pay...",
        "url": "https://finnhub.io/api/news?id=167986ed0244efbe281992df52af706a6609f77769da24a96bc7cc5bcfe8f46f"
    },
    {
        "category": "company",
        "datetime": 1730884260,
        "headline": "Is It Time to Buy October's Worst-Performing Nasdaq Stocks?",
        "id": 131103155,
        "image": "https://g.foolcdn.com/editorial/images/796649/buy-sell-metal-dice-470277287.jpg",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.",
        "url": "https://finnhub.io/api/news?id=70268b01c3d0fc0deb788cdd5946a643a22f68e6f75d0f388713336222ec7a3d"
    },
    {
        "category": "company",
        "datetime": 1730818380,
        "headline": "A Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent Pullback",
        "id": 131094313,
        "image": "https://g.foolcdn.com/editorial/images/795979/gettyimages-530977027-5.jpg",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Trading at its most reasonable valuation since 2016, this pet healthcare diagnostics leader could be a once-in-a-decade opportunity today.",
        "url": "https://finnhub.io/api/news?id=a8c3f4d2ed393299f9c5792d6cde3c0619a95ec396f1ae96542f7a1fcb0844c7"
    },
    {
        "category": "company",
        "datetime": 1730760198,
        "headline": "IDEXX Laboratories, Inc. 2024 Q3 - Results - Earnings Call Presentation",
        "id": 131064482,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "The following slide deck was published by IDEXX Laboratories, Inc.",
        "url": "https://finnhub.io/api/news?id=5fc69af8c0b14fcea6be78a5c7ecc6570c4f8f6e1a53cff1d1607d7b4405d93a"
    },
    {
        "category": "company",
        "datetime": 1730481874,
        "headline": "Here\u2019s Why Aristotle Focus Growth Strategy Sold IDEXX Laboratories  (IDXX)",
        "id": 130982959,
        "image": "https://media.zenfs.com/en/insidermonkey.com/2cd8148157cf1b7ad501c38998155fc7",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Aristotle Atlantic Partners, LLC, an investment advisor, released its \u201cFocus Growth Strategy\u201d third quarter 2024 investor letter. A copy of the letter can be downloaded here. The U.S. equity market continued its rise to new record highs, with the S&P 500 Index increasing by 5.89% during the period. Aristotle Atlantic\u2019s Focus Growth strategy returned 2.84% [\u2026]",
        "url": "https://finnhub.io/api/news?id=c177e15e7f15a802a7668bd85200f5dbb983a682461a3e96d51b82c8d0efb6d4"
    },
    {
        "category": "company",
        "datetime": 1730468100,
        "headline": "Healthcare Investing Finding Growth Beyond Pharmaceuticals",
        "id": 130963540,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1358927461/image_1358927461.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Companies that manufacture diagnostics, technology and equipment to address the world\u00e2\u0080\u0099s most pressing medical issues have become increasingly important for progress in the healthcare sector.",
        "url": "https://finnhub.io/api/news?id=ad1b4b6c3f813c7f85f27f25700e801084507d56a7c48c95ab698186bebccff4"
    },
    {
        "category": "company",
        "datetime": 1730459100,
        "headline": "IDEXX Laboratories Inc (IDXX) Stock Price Up 3.56% on Nov 1",
        "id": 130970813,
        "image": "",
        "related": "IDXX",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=8365d724a60d261249bfef5227ede752982529fe149d97e2e23487c5c7f3fa3c"
    },
    {
        "category": "company",
        "datetime": 1730457591,
        "headline": "IDEXX Laboratories Announces Third Quarter Results",
        "id": 130955554,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "WESTBROOK - IDEXX Laboratories, Inc. , a global leader in pet healthcare innovation, today announced third quarter results.Third Quarter ResultsThe Company reports revenues of $976 million for the...",
        "url": "https://finnhub.io/api/news?id=e0c788d04d9cc4b17643568eedc7c1bbe7abae52d0566e6bf806c6d48bdd554f"
    },
    {
        "category": "company",
        "datetime": 1730444760,
        "headline": "Idexx Laboratories: Strong Financial Performance and Strategic Positioning Justify Buy Rating",
        "id": 130970814,
        "image": "",
        "related": "IDXX",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=64e243ae6d522f0a17ce1ff4fd03e1ca2ac554ac21e12437cdd4a465391babca"
    },
    {
        "category": "company",
        "datetime": 1730444719,
        "headline": "IDEXX Laboratories Inc (IDXX) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market ...",
        "id": 130945163,
        "image": "",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories Inc (IDXX) reports robust earnings growth with a focus on innovation, despite facing macroeconomic pressures and sector headwinds.",
        "url": "https://finnhub.io/api/news?id=466546622c88c746a0f646e680abc3e3a02658c8f6be7be85b2f1b3106ed3235"
    },
    {
        "category": "company",
        "datetime": 1730444509,
        "headline": "Q3 2024 IDEXX Laboratories Inc Earnings Call",
        "id": 130945165,
        "image": "",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Q3 2024 IDEXX Laboratories Inc Earnings Call",
        "url": "https://finnhub.io/api/news?id=d90060f38ab06857c094eabdafd222d0d1ad4c030541f5c016911e70d1535ba9"
    },
    {
        "category": "company",
        "datetime": 1730434260,
        "headline": "Idexx Laboratories Hold Rating: Navigating Uncertain Growth and Market Pressures",
        "id": 130970815,
        "image": "",
        "related": "IDXX",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=6e0c2039bcf22814e451d573cd7a28f8b5ff5b26e734e5db05860dba5d3a9a9b"
    },
    {
        "category": "company",
        "datetime": 1730394900,
        "headline": "CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results",
        "id": 130906572,
        "image": "https://s.yimg.com/ny/api/res/1.2/nLA.Rg0_adAVxQvQk6osYw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0yMjA-/https://media.zenfs.com/en/business-wire.com/22d92831c7aab7384e0806f7ebdbf7f2",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "WESTBROOK, Maine, October 31, 2024--In the 2024 Growth and Financial Performance Outlook section, second paragraph, second sentence should read: At midpoint, projected full year comparable operating profit margin expansion of 30 - 60 basis points includes a ~40 basis point negative growth impact from lapping a customer contract resolution payment in the first quarter of 2023. (instead of: At midpoint, projected full year comparable operating profit margin expansion of 70 - 100 basis points inclu",
        "url": "https://finnhub.io/api/news?id=6ce3c2a3648531071d254f987a62ed92c8aba020fe6e2f482de46e47585ce06b"
    },
    {
        "category": "company",
        "datetime": 1730387220,
        "headline": "IDXX Q3 Earnings Top, '24 Sales View Down, Stock Dips in Premarket",
        "id": 130906573,
        "image": "https://media.zenfs.com/en/zacks.com/0e6e00119767dea571e2db52c929df03",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDXX's Q3 revenues benefit from strong growth in its CAG and Water segments.",
        "url": "https://finnhub.io/api/news?id=d0840a64ce4ced6fd26780a038d40b576d03ac6e34ab58a78702a0506b604392"
    },
    {
        "category": "company",
        "datetime": 1730383147,
        "headline": "IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript",
        "id": 130907666,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ETCompany ParticipantsBrian McKeon - CFOJay Mazelsky -...",
        "url": "https://finnhub.io/api/news?id=cde7112d89b019042e27f3f19e2833dce5897978adaac0c91d52d6840329e484"
    },
    {
        "category": "company",
        "datetime": 1730381443,
        "headline": "Idexx (IDXX) Reports Q3 Earnings: What Key Metrics Have to Say",
        "id": 130906576,
        "image": "https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
        "url": "https://finnhub.io/api/news?id=b8e3eae1bfc2b0142721076d9f1d37bfdd38c09b40e32cf9ffe97dfc9ae06686"
    },
    {
        "category": "company",
        "datetime": 1730376024,
        "headline": "Calculating The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)",
        "id": 130906577,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Key Insights Using the 2 Stage Free Cash Flow to Equity, IDEXX Laboratories fair value estimate is US$441 Current share...",
        "url": "https://finnhub.io/api/news?id=c6fa845ed56d1da723c758b74dbdeb61f3f2e69539a2a4d59b1685a2489f834e"
    },
    {
        "category": "company",
        "datetime": 1730375400,
        "headline": "IDEXX stock falls 10% on Q3 revenue miss, lowered guidance",
        "id": 130933989,
        "image": "",
        "related": "IDXX",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=5ac6ffcf274cdf427c3df50bd601aa5abdcccb70813341dd2caa24996b0621ac"
    },
    {
        "category": "company",
        "datetime": 1730375160,
        "headline": "IDEXX Laboratories Reports Robust Q3 2024 Performance",
        "id": 130970817,
        "image": "",
        "related": "IDXX",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=78f2551d1298b53a0aa40eb12ea9aedcb8d1e300e8e211f209b089e741c5b0bf"
    },
    {
        "category": "company",
        "datetime": 1730374805,
        "headline": "Idexx Laboratories (IDXX) Q3 Earnings Surpass Estimates",
        "id": 130906579,
        "image": "https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Idexx (IDXX) delivered earnings and revenue surprises of 4.09% and 0.41%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
        "url": "https://finnhub.io/api/news?id=e2baf3cee762022776f02e60cd169da7e798f1318cc0c05b001228057247f0e2"
    },
    {
        "category": "company",
        "datetime": 1730372580,
        "headline": "IDEXX Laboratories Inc (IDXX) Shares Down 9.01% on Oct 31",
        "id": 130933992,
        "image": "",
        "related": "IDXX",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=999793f38428788d2b8f0e7ffec576c9e50c26c882549c2e982f29db044654fa"
    },
    {
        "category": "company",
        "datetime": 1730371298,
        "headline": "Idexx: Q3 Earnings Snapshot",
        "id": 130906581,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "WESTBROOK, Maine (AP) \u2014 Idexx Laboratories Inc. IDXX) on Thursday reported third-quarter earnings of $232.8 million. On a per-share basis, the Westbrook, Maine-based company said it had profit of $2.80.",
        "url": "https://finnhub.io/api/news?id=595e3c416915f4a9e73f88e52a68a3a85817062e4cc14c30cf5da4dad681559b"
    },
    {
        "category": "company",
        "datetime": 1730357224,
        "headline": "IDEXX Laboratories : Q3 2024 Earnings Snapshot",
        "id": 130892791,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "IDEXX Q3 2024 Earnings Highlights Revenue ...",
        "url": "https://finnhub.io/api/news?id=dbab8e08490380351ff1de811ee71f5f57081d877125f7c460486f5d8efece94"
    },
    {
        "category": "company",
        "datetime": 1730357223,
        "headline": "IDEXX Laboratories : Achieves third quarter revenue growth of 7% as reported and 6% organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic Form 8 K",
        "id": 130892800,
        "image": "",
        "related": "IDXX",
        "source": "Finnhub",
        "summary": "Achieves third quarter revenue growth of 7% as reported and 6% organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic. ...",
        "url": "https://finnhub.io/api/news?id=5736891c6199c0c112da34705964e219b9ebba3e0a34e3ebc766a4168382ed32"
    },
    {
        "category": "company",
        "datetime": 1730354580,
        "headline": "Idexx Laboratories narrows 2024 EPS view to $10.37-$10.53 from $10.31-$10.59",
        "id": 130933994,
        "image": "",
        "related": "IDXX",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=ad9c9d50f2da13030da16088af1222f581480c61c4909691d38fc6d2fa69aaf9"
    },
    {
        "category": "company",
        "datetime": 1730354160,
        "headline": "Idexx Laboratories reports Q3 EPS $2.80, consensus $2.68",
        "id": 130933997,
        "image": "",
        "related": "IDXX",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=ed0f6e799dc24ffc5035000d1b0f1727c20fc815b0cd08741d4805972baff432"
    },
    {
        "category": "company",
        "datetime": 1730353980,
        "headline": "IDEXX Laboratories Q3 2024 Earnings: EPS at $2.80, Revenue Misses Estimates at $976 Million",
        "id": 130934001,
        "image": "",
        "related": "IDXX",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=92a947ed8b1fde7cfc5a8e6b16d5c46e10cfdad459e3a8ba8cfa4f4e4f047ac7"
    },
    {
        "category": "company",
        "datetime": 1730352960,
        "headline": "IDEXX Laboratories Non-GAAP EPS of $2.79 beats by $0.10, revenue of $975.54M misses by $5.42M",
        "id": 130934003,
        "image": "",
        "related": "IDXX",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=49d44facb4d34d661cef90a6b372a6f52124d75188be60dfc7f56cd6784c1443"
    },
    {
        "category": "company",
        "datetime": 1730346480,
        "headline": "Barclays Sticks to Its Buy Rating for Idexx Laboratories (IDXX)",
        "id": 130934006,
        "image": "",
        "related": "IDXX",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=482f720f39adda19929391bed8018edf93e40c405aa8bdda3f4ac057dcb82991"
    },
    {
        "category": "company",
        "datetime": 1730283720,
        "headline": "IDEXX Laboratories Q3 2024 Earnings Preview",
        "id": 130862324,
        "image": "",
        "related": "IDXX",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=fe28c999f4dfef71be6b1f056dbd30bbc5f5d71e4d9f83107bc161e6001cc352"
    },
    {
        "category": "company",
        "datetime": 1730278800,
        "headline": "Put underwriting and put buying opportunities within the Russell 1000 \u2013 JPM",
        "id": 130854682,
        "image": "",
        "related": "IDXX",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=f1b168c31878abf61c4855edd7054194f6a6a1cacfa4304ecd04380a444c2a98"
    },
    {
        "category": "company",
        "datetime": 1730121365,
        "headline": "Seeking Clues to Idexx (IDXX) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics",
        "id": 130797620,
        "image": "https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Evaluate the expected performance of Idexx (IDXX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
        "url": "https://finnhub.io/api/news?id=20a04f656bf924daf345b11781b53a2a200865ff7875bc0a3510b57d4b7ad1dd"
    },
    {
        "category": "company",
        "datetime": 1730116740,
        "headline": "IDEXX Labs added as a new short idea at Hedgeye",
        "id": 130783257,
        "image": "",
        "related": "IDXX",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=df4be24870cbdb56deb8f659f2f4ac904d12b7706a1bfaa96ed2231dbd370cc0"
    },
    {
        "category": "company",
        "datetime": 1729864831,
        "headline": "Waters (WAT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?",
        "id": 130735675,
        "image": "https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
        "url": "https://finnhub.io/api/news?id=8e88de9c46b099ea239ad8f182d42f5bd638463ee105e0b91fc51de53a087faa"
    },
    {
        "category": "company",
        "datetime": 1729778485,
        "headline": "Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?",
        "id": 130716259,
        "image": "https://s.yimg.com/ny/api/res/1.2/gZA5XMnsr1RRZw6lGNAcdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05NDA-/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
        "url": "https://finnhub.io/api/news?id=6c39433dfdcd17c798c50815389eb92a0d6a77301bcfd9806ef1d21077663d28"
    },
    {
        "category": "company",
        "datetime": 1729772820,
        "headline": "Conestoga Capital Advisors Q3 2024 Quarterly Commentary",
        "id": 130699203,
        "image": "",
        "related": "IDXX",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=3b55f3db0c131425b8b8d91df4a08298a5456a8fbebf1619fdc8068d9c09196b"
    },
    {
        "category": "company",
        "datetime": 1729770000,
        "headline": "Baron Focused Growth Fund Q3 2024 Shareholder Letter",
        "id": 130699173,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1487894858/image_1487894858.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Baron Focused Growth Fund had strong relative and absolute performance in Q3 increasing 11.77% vs. the Russell 2500 Growth Index, which increased 6.99%.",
        "url": "https://finnhub.io/api/news?id=1a8406882443363ca10d40256aabf65dd2284506832f4ee55a613c0d090bf5a0"
    },
    {
        "category": "company",
        "datetime": 1729736580,
        "headline": "ESG \u2018transition\u2019 funds are an emerging trend \u2013 Here the most overweight stocks by ESG funds",
        "id": 130703877,
        "image": "",
        "related": "IDXX",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=1c64ee0b1e0db2606f1b9c5e6048ad242ae5168d551f44a018876ad244684294"
    },
    {
        "category": "company",
        "datetime": 1729086360,
        "headline": "IDXX Gears Up for Q3 Earnings: What to Expect From the Stock?",
        "id": 130518558,
        "image": "https://media.zenfs.com/en/zacks.com/08d295f8913d1d597be87f944e8a8f5c",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories' third-quarter 2024 performance is expected to have benefited from a strong execution against strategic priorities.",
        "url": "https://finnhub.io/api/news?id=489d3da0c3262d2734415cb71e67143137ce1f2c1311ceb60ecb9561c038fda1"
    },
    {
        "category": "company",
        "datetime": 1729062360,
        "headline": "Idexx Laboratories (IDXX) Receives a Hold from Piper Sandler",
        "id": 130490601,
        "image": "",
        "related": "IDXX",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=80c80f282c28fcbd488fd7fbd3f28f2f3c7e19cc089fde184e480f4b31c573a2"
    },
    {
        "category": "company",
        "datetime": 1728986580,
        "headline": "First Week of April 2025 Options Trading For Idexx Laboratories (IDXX)",
        "id": 130476122,
        "image": "",
        "related": "IDXX",
        "source": "Stock Options Channel",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=fcc92d7da751420e10976800df4be2a38b9c46975195236257f498aa41380f5c"
    },
    {
        "category": "company",
        "datetime": 1728901380,
        "headline": "Morgan Stanley screens for quality cyclicals as economic surprises, yields back upgrade",
        "id": 130444988,
        "image": "",
        "related": "IDXX",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=6bdf65cd8bd08f82d9672e4282aeae3ab3e9d6a019da357a2f8a746e810f7af1"
    },
    {
        "category": "company",
        "datetime": 1728655220,
        "headline": "Here's What IDEXX Laboratories' (NASDAQ:IDXX) Strong Returns On Capital Mean",
        "id": 130391134,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...",
        "url": "https://finnhub.io/api/news?id=238597348cf6481316b42e60e8a00d824a5aff478c294a1c17cfd83ec1b160fd"
    },
    {
        "category": "company",
        "datetime": 1728651972,
        "headline": "Idexx Laboratories price target lowered to $500 from $510 at Stifel",
        "id": 130391136,
        "image": "",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Stifel lowered the firm\u2019s price target on Idexx Laboratories to $500 from $510 and keeps a Hold rating on the shares. The firm believes the long-term company fundamentals \u201cremain largely intact,\u201d but believes price will inevitably need to come down looking ahead, which will put greater pressure on visits and innovation, and believes the company\u2019s latest innovation \u2013 the inVue Dx analyzer \u2013 will not contribute meaningfully to CAG diagnostic recurring revenue growth until 2026. Published first on",
        "url": "https://finnhub.io/api/news?id=c4f82dcfcbffd5d81af2bc5cb7be658dd91bf26582f1b39f57cf4200968471ea"
    },
    {
        "category": "company",
        "datetime": 1728572103,
        "headline": "Is IDEXX Laboratories Inc. (IDXX) the Best Quality Stock to Buy According to Analysts?",
        "id": 130372544,
        "image": "https://s.yimg.com/ny/api/res/1.2/49Eav.P8JXuAIU2r8SjZcQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "We recently compiled a list of 10 Best Quality Stocks to Buy According to Analysts. In this article, we will look at where IDEXX Laboratories Inc. (NASDAQ:IDXX) ranks among the best-quality stocks to buy. Income-Focused Investing The stock market has seen a notable 20% increase year-to-date, but as it approaches the seasonally volatile months leading [\u2026]",
        "url": "https://finnhub.io/api/news?id=9563c03e2b69f302a992cbdb8cbe8f0ddf72ad57ef552d19f577e424a3681c9f"
    },
    {
        "category": "company",
        "datetime": 1728563520,
        "headline": "$100 Invested In This Stock 20 Years Ago Would Be Worth $1,000 Today",
        "id": 130368557,
        "image": "",
        "related": "IDXX",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=70d939c084947a239448a5c7c7c89e92ccfac53ef224c0c017c054181c2d884f"
    },
    {
        "category": "company",
        "datetime": 1728547260,
        "headline": "Idexx Laboratories price target lowered by $10 at Stifel, here's why",
        "id": 130368559,
        "image": "",
        "related": "IDXX",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=f8ad42a4577f25d311617a3350bd64cbfdbe9770700718ad4792d9eddaeb8952"
    },
    {
        "category": "company",
        "datetime": 1728396960,
        "headline": "Are Options Traders Betting on a Big Move in IDEXX Laboratories (IDXX) Stock?",
        "id": 130283113,
        "image": "https://media.zenfs.com/en/zacks.com/81880a99f954ad6a8713d0d282dde701",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Investors need to pay close attention to IDEXX Laboratories (IDXX) stock based on the movements in the options market lately.",
        "url": "https://finnhub.io/api/news?id=4500138fe060db2ff2787cf83ff5b35d486b7d2c4610f42b18d8e0913e26227f"
    },
    {
        "category": "company",
        "datetime": 1728233623,
        "headline": "IDEXX Laboratories Inc. (IDXX): Analysts Are Bullish On This Quality Stock Right Now",
        "id": 130248598,
        "image": "https://s.yimg.com/ny/api/res/1.2/49Eav.P8JXuAIU2r8SjZcQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "We recently compiled a list of the 10 Best Quality Stocks to Buy According to Analysts. In this article, we are going to take a look at where IDEXX Laboratories Inc. (NASDAQ:IDXX) stands against the other quality stocks. Income-Focused Investing The stock market has seen a notable 20% increase year-to-date, but as it approaches the seasonally [\u2026]",
        "url": "https://finnhub.io/api/news?id=e4b91b7ba43c999133da3107492c1b67e027987abf4b014c960b8fca796dd772"
    },
    {
        "category": "company",
        "datetime": 1728219623,
        "headline": "Should You Think About Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX) Now?",
        "id": 130248599,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) received a lot of attention from a substantial price movement on the NASDAQGS...",
        "url": "https://finnhub.io/api/news?id=90220c62125cbd5b32520dcd1635ccefd3697bd2320fd4a16dbdd41cd2a4e274"
    },
    {
        "category": "company",
        "datetime": 1727719200,
        "headline": "IDEXX Laboratories to Release 2024 Third Quarter Financial Results",
        "id": 130153640,
        "image": "https://s.yimg.com/ny/api/res/1.2/u7SRD9LU_9s1QjUuhgI9Dg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0yMjA-/https://media.zenfs.com/en/business-wire.com/0af344087228b13d78d43461173cfae1",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "WESTBROOK, Maine, September 30, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 third quarter results for Thursday, October 31, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day.",
        "url": "https://finnhub.io/api/news?id=8aaae950aae9f7b6f1a691f69e918f8264123c363d274455878c20667f86b688"
    },
    {
        "category": "company",
        "datetime": 1727704861,
        "headline": "IDEXX Laboratories (NASDAQ:IDXX) Ticks All The Boxes When It Comes To Earnings Growth",
        "id": 130153641,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...",
        "url": "https://finnhub.io/api/news?id=0f2d42fe16acd1e1389dc8a76d832c9f3e2f3a16ba98e7197b3533951e029882"
    },
    {
        "category": "company",
        "datetime": 1727418180,
        "headline": "Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years",
        "id": 130123039,
        "image": "",
        "related": "IDXX",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=b6b687cf54e57a1c7ae05951fbe4a50005ecadc8dfd1e1b1dea7c2ab5c968fa0"
    },
    {
        "category": "company",
        "datetime": 1727013609,
        "headline": "A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)",
        "id": 130015595,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Key Insights The projected fair value for IDEXX Laboratories is US$442 based on 2 Stage Free Cash Flow to Equity With...",
        "url": "https://finnhub.io/api/news?id=7d7b5735be21897e8bae39cec1a4a42bfa1f3c0b0dd3ae45a29cff47ace8c6c0"
    },
    {
        "category": "company",
        "datetime": 1726812900,
        "headline": "American Century Sustainable Equity Fund Q2 2024 Commentary",
        "id": 129981657,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1561104545/image_1561104545.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Our process uses bottom-up analysis aimed at identifying what we believe are growing, large-cap companies demonstrating sustainable corporate behaviors.",
        "url": "https://finnhub.io/api/news?id=468c74633c636e550492512880e5f8f85117fddc4c7e525eb1237045b328ab9f"
    },
    {
        "category": "company",
        "datetime": 1726783304,
        "headline": "Tracking Ron Baron's BAMCO Portfolio - Q2 2024 Update",
        "id": 129976670,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1056792912/image_1056792912.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "An analysis of BAMCO Inc. and Baron Capital's 13F portfolios shows stake changes in Tesla, Arch Capital, Gartner, and other companies. Read more here.",
        "url": "https://finnhub.io/api/news?id=6b61aaa22c7c9330260c8ee5a799257ea05f0c00ad7694528bbe42b2d8d38815"
    },
    {
        "category": "company",
        "datetime": 1726569000,
        "headline": "Bullish Two Hundred Day Moving Average Cross - IDXX",
        "id": 129935130,
        "image": "",
        "related": "IDXX",
        "source": "Market News Video",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=17c3a38a178a94fce6880bd1d68ac3535b704f1fbf11a51b27b2da5ea13a3b78"
    },
    {
        "category": "company",
        "datetime": 1726142435,
        "headline": "IDEXX Laboratories' (NASDAQ:IDXX) five-year earnings growth trails the favorable shareholder returns",
        "id": 129844643,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can do a lot better...",
        "url": "https://finnhub.io/api/news?id=df9a4bf305082faf3031152833b14c77813bfc38583ed1bbdbc3eaaa38f7168f"
    },
    {
        "category": "company",
        "datetime": 1726049220,
        "headline": "IDEXX Laboratories Inc (IDXX) Trading Down 3.59% on Sep 11",
        "id": 129833633,
        "image": "",
        "related": "IDXX",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=75db0d02c2cb796f87e3301ed57fb19ce44ffe90cd5db264d64ab2ad1c1a3bd5"
    },
    {
        "category": "company",
        "datetime": 1725962520,
        "headline": "IDEXX Laboratories Inc (IDXX)'s Winning Formula: Financial Metrics and Competitive Strengths",
        "id": 129803788,
        "image": "",
        "related": "IDXX",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=70630200a0844e2cf99602097f117723ef26d57fa95906079ea528eacfd02fc6"
    },
    {
        "category": "company",
        "datetime": 1725945420,
        "headline": "IDEXX Laboratories Inc (IDXX) Trading 3.25% Higher on Sep 10",
        "id": 129833634,
        "image": "",
        "related": "IDXX",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=59da7600be9a0fa9b3ac52a3c775244158571aa7cf6beedbcd631dee1d0e59c4"
    },
    {
        "category": "company",
        "datetime": 1725550275,
        "headline": "Why Is Idexx (IDXX) Up 0.9% Since Last Earnings Report?",
        "id": 129736687,
        "image": "https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
        "url": "https://finnhub.io/api/news?id=6e233b2d98e074b03259dff1c3c394e8112ba44f2fec66cd321c8afbaa696db5"
    },
    {
        "category": "company",
        "datetime": 1725528900,
        "headline": "Fidelity Growth Strategies Fund Q2 2024 Review",
        "id": 129726315,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1489363303/image_1489363303.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Fidelity Growth Strategies Fund is a diversified domestic equity strategy with a mid-cap growth orientation.",
        "url": "https://finnhub.io/api/news?id=eec7ad51e5167ef66ae535aa2bdcc269bd5ed7f8132a2a4e8736879c434e3301"
    },
    {
        "category": "company",
        "datetime": 1725458419,
        "headline": "What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?",
        "id": 129725019,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) received a lot of attention from a substantial price movement on the NASDAQGS...",
        "url": "https://finnhub.io/api/news?id=bf864d51d42d845b9b2e6752d12969f92c32792e95d021bead6198d82f7627f5"
    },
    {
        "category": "company",
        "datetime": 1724853780,
        "headline": "Do Options Traders Know Something About IDEXX (IDXX) Stock We Don't?",
        "id": 129597850,
        "image": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Investors need to pay close attention to IDEXX (IDXX) stock based on the movements in the options market lately.",
        "url": "https://finnhub.io/api/news?id=5169db450ed61dc202648a587de95a0e0556e6c6b62304e5921dab27f000946b"
    },
    {
        "category": "company",
        "datetime": 1724799482,
        "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2024 Update",
        "id": 129590354,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/538053368/image_538053368.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Fundsmith\u00e2\u0080\u0099s 13F portfolio value decreased from $25.55B to $24.54B this quarter. Click here for a detailed analysis.",
        "url": "https://finnhub.io/api/news?id=913b61631f0673a01fc4a165da541a023bc76e8364569871219c73441d1a25d4"
    },
    {
        "category": "company",
        "datetime": 1724756423,
        "headline": "Investors Shouldn't Overlook The Favourable Returns On Capital At IDEXX Laboratories (NASDAQ:IDXX)",
        "id": 129578240,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...",
        "url": "https://finnhub.io/api/news?id=b213be60ec7fdd46fa5256838bbeea72b41ad98469df0124aff89ca0687b7261"
    },
    {
        "category": "company",
        "datetime": 1724445240,
        "headline": "This State Is Showing Surprising Strength. Why You Can\u2019t Get There From Here.",
        "id": 129534137,
        "image": "https://s.yimg.com/ny/api/res/1.2/lCTLhrtHhOfOJx6aSREw1A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/05459dcbeeb2d57ae034c71dacffa546",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "The state encapsulates broader changes for the U.S. that have been brought about by remote work, labor shortages, and elevated real estate prices.",
        "url": "https://finnhub.io/api/news?id=a579fd9c00091de8ff44a95dd412ff8d730c215281b4b4c446ee1d676d472a88"
    },
    {
        "category": "company",
        "datetime": 1724408730,
        "headline": "A Look At The Fair Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)",
        "id": 129523022,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "Key Insights Using the 2 Stage Free Cash Flow to Equity, IDEXX Laboratories fair value estimate is US$445 With US$492...",
        "url": "https://finnhub.io/api/news?id=f6a09f358a52227ecebfa4e4182ca5321ade369f91b9c3e65b15546f6945c325"
    },
    {
        "category": "company",
        "datetime": 1724271300,
        "headline": "IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference",
        "id": 129490695,
        "image": "https://s.yimg.com/ny/api/res/1.2/sQS2p4L8kfogNYkjDz_eaQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0yMjA-/https://media.zenfs.com/en/business-wire.com/66a2d18c7267f7d81599c44c39fb6126",
        "related": "IDXX",
        "source": "Yahoo",
        "summary": "WESTBROOK, Maine, August 21, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024 from 11:30 am \u2013 12:05 pm (EDT).",
        "url": "https://finnhub.io/api/news?id=44f9267dd33feb6918b3f3c0d87efd6f2e46b33938caba034893a590f0e7ce54"
    },
    {
        "category": "company",
        "datetime": 1724065380,
        "headline": "$100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today",
        "id": 129449519,
        "image": "",
        "related": "IDXX",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=7e2922385b79d3c68471f74af2adf17be0ffe102a25e164552ce66d9a06cfe9b"
    },
    {
        "category": "company",
        "datetime": 1723855200,
        "headline": "Baron Asset Fund Q2 2024 Shareholder Letter",
        "id": 129418014,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/943331302/image_943331302.jpg?io=getty-c-w1536",
        "related": "IDXX",
        "source": "SeekingAlpha",
        "summary": "Baron Asset Fund declined in the second quarter of 2024, in line with its benchmark, the Russell Midcap Growth Index, in a challenging quarter for mid-cap growth stocks.",
        "url": "https://finnhub.io/api/news?id=523d0a59b2ca15053d74220466ae6b564b7a92e960d2dc2e299529a2cbfdc815"
    }
]